FIELD: organic chemistry.
SUBSTANCE: invention relates to the field of organic chemistry, namely to a heterocyclic compound of formula II or IV, to its racemate, enantiomer, diastereoisomer or a pharmaceutically acceptable salt, where M is H or Na ion; U represents 
, 
 or 
; X1 represents CH, Y represents 
; each of X7 and X8 independently represents CH or S; each of R1 and R2 independently represents H, C1-4 alkyl; or R1, R2 together with the carbon atom to which they are attached form C3-6 cycloalkyl; wherein alkyl may be further substituted with 3 D substituents; R3 is H or halogen; R4 represents C6-10 aryl or 
; wherein aryl or 
 is substituted with 1–2 substituents selected from the group consisting of halogen and CN; each of R5 and R6 independently represents H, OH or C1-4 alkyl; n is 0 or 1; p is 1; or a derivative with articulated rings, which is selected from the compounds mentioned in claim 1 of the claims. Invention also relates to intermediate compounds of formulas II-a or IV-a, the use of a compound of formula II or IV and a pharmaceutical composition based on a compound of formula II or IV. 
        
      
        
 
.
EFFECT: technical result: new heterocyclic compounds have been obtained that are useful in the treatment of hyperuricemia or a disease associated with hyperuricemia.
12 cl, 1 ex, 1 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| NITROGEN-CONTAINING HETEROCYCLIC AROMATIC COMPOUND, METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND USE THEREOF | 2017 | 
									
  | 
                RU2729999C1 | 
| RESORCINOL DERIVATIVE AS HSP90 INHIBITOR | 2016 | 
									
  | 
                RU2697703C2 | 
| ANALOGUE OF BENZOFURANE AS NS4B INHIBITOR | 2015 | 
									
  | 
                RU2672257C2 | 
| PENTACYCLIC HETEROCYCLIC COMPOUND | 2020 | 
									
  | 
                RU2815382C2 | 
| GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 | 
									
  | 
                RU2805308C2 | 
| QUINOLINE DERIVATIVES AS SMO INHIBITORS | 2015 | 
									
  | 
                RU2695815C2 | 
| HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 | 
									
  | 
                RU2615130C2 | 
| PYRUVATEKINASE MODULATORS AND THEIR USE | 2018 | 
									
  | 
                RU2797518C2 | 
| HETEROCYCLIC COMPOUND OF PYRIMIDIN-4(3H)-ONE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2021 | 
									
  | 
                RU2839367C1 | 
| MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF THEIR APPLICATION | 2019 | 
									
  | 
                RU2797558C2 | 
Authors
Dates
2019-03-29—Published
2016-02-01—Filed